Latest Federal Register Notices

Public Workshop on Engaging With CDER 03/31/2017
Federal Register notice. CDER announces a 5/12 public workshop on a “Roadmap for Engaging with FDA’s Center for Drug Evaluation and Research (CDER).”

Comments Sought on Cell Tissue Product Info. Collection 03/31/2017
Federal Register notice: FDA seeks comments on an information collection extension on “Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P) : Establishment Registration and Listing; Eligibility Determination for Donors; and Current Good Tissue Practice.”

Comments Sought on Graphic Health Warnings 03/28/2017
Federal Register notice: FDA requests public comments on a new information collection related to a proposed “Experimental Study on Warning Statements for Cigarette Graphic Health Warnings.”

Draft Guide on Kidney Transplantation Drugs 03/24/2017
Federal Register notice: FDA announces the availability of a draft guidance on “Delayed Graft Function in Kidney Transplantation: Developing Drugs for Prevention.”